Melanoma Clinical Trials

Open to recruitment

NICAM: A Phase II Trial of Nilotinib in the treatment of patients with c-KIT mutated advanced acral and mucosal melanoma. NICAM is a single arm Phase II trial for patients with advanced c-KIT mutated acral or mucosal melanoma.

In active follow-up

MSG/BAPS: MSG/BAPS randomised trial of width of excision of thick cutaneous malignant melanoma.

SLNB: The Sentinel Lymph Node Biopsy study is a randomised, feasibility study investigating the diagnosis and treatment of early lymph node involvement in patients with primary cutaneous melanoma by sentinel lymph node biopsy with or without completion lymphadenectomy and molecular markers.